Aventis filed the lawsuit in the U.S. District Court for the District of Delaware on Wednesday, asserting two patents that the Delaware court found to be invalid in September in a related case Aventis brought against Hospira Inc. and Apotex Inc. that is currently on appeal.

Sanofi-Aventis US holds an approved new drug application for Taxotere's active ingredient,...